4//SEC Filing
Rosol Michael Stanley 4
Accession 0001437749-22-022307
CIK 0000810509other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:07 PM ET
Size
6.8 KB
Accession
0001437749-22-022307
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Common Stock
2022-09-09+28,150→ 42,725 total - Award
Common Stock
2022-09-09+13,000→ 55,725 total
Holdings
- 11,320(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]The Reporting Person elected to receive stock in lieu of a cash bonus. The number of shares was determined based on the closing price on the date of grant, September 9, 2022.
- [F2]Stock Issued under the Amended and Restated 2014 Stock Incentive Plan.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001762349
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:07 PM ET
- Size
- 6.8 KB